Details of the Drug
General Information of Drug (ID: DMMYQ9R)
| Drug Name |
2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole; 31659-42-4; 1h-imidazole, 4,5-dihydro-2-(3-nitrophenyl)-; CHEMBL457101; 4,5-Dihydro-2-(3-nitrophenyl)-1H-imidazole; EINECS 250-754-1; AC1LEYVJ; AC1Q1ZUC; 2-(m-nitrophenyl)imidazoline; IMI021; SCHEMBL12643294; CTK4G7541; DTXSID30185551; MolPort-006-126-327; ZINC121568; 2-(3-Nitrophenyl)-2-imidazoline; STK367845; BDBM50266032; BBL001160; AKOS005444754; MCULE-9494328291; T7684
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 191.19 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.7 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


